首页> 外文期刊>Oncology letters >Role of hypoxia-inducible factor-1α, carbonic anhydrase-IX, glucose transporter-1 and vascular endothelial growth factor associated with lymph node metastasis and recurrence in patients with locally advanced cervical cancer
【24h】

Role of hypoxia-inducible factor-1α, carbonic anhydrase-IX, glucose transporter-1 and vascular endothelial growth factor associated with lymph node metastasis and recurrence in patients with locally advanced cervical cancer

机译:缺氧诱导因子-1α,碳酸酐酶-IX,葡萄糖转运蛋白-1和血管内皮生长因子在局部晚期宫颈癌患者中与淋巴结转移和复发的关系

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to determine whether the expression of hypoxia-inducible factor-1α (HIF-1α), carbonic anhydrase-IX (CA-IX), glucose transporter-1 (GLUT-1) or vascular endothelial growth factor (VEGF) was associated with the clinicopathological characteristics, lymph node metastasis or progression-free survival of patients with cervical cancer. Tumor tissue samples were obtained from 54 cervical cancer patients who had undergone radical hysterectomy. The expression of HIF-1α, CA-IX, GLUT-1 and VEGF was analyzed by immunohistochemical staining. Of the 54 cases, 28 were positive for HIF-1α, 35 for CA-IX, 40 for GLUT-1 and 23 for VEGF. It was revealed that HIF-1α expression was correlated with tumor stage and histology, CA-IX expression with tumor stage, tumor size, lymph node metastasis and lymph-vascular space involvement, GLUT-1 expression with tumor stage and lymph-vascular space involvement, and VEGF expression with microvessel density. The multivariate regression analysis indicated that CA-IX expression and lymph-vascular space involvement were independent variables associated with lymph node metastasis. Progression-free survival was shorter for patients who were positive for CA-IX or VEGF expression than for those who were negative for CA-IX or VEGF expression. The progression-free survival of patients treated with radiotherapy or chemo-radiotherapy following radical hysterectomy was also shorter for patients with positive CA-IX expression. These findings suggest that CA-IX expression is a possible risk factor for lymph node metastasis and disease recurrence in locally advanced cervical cancer patients.
机译:本研究的目的是确定低氧诱导因子-1α(HIF-1α),碳酸酐酶-IX(CA-IX),葡萄糖转运蛋白-1(GLUT-1)或血管内皮生长因子的表达( VEGF)与宫颈癌患者的临床病理特征,淋巴结转移或无进展生存期相关。肿瘤组织样本取自54例接受了全子宫切除术的宫颈癌患者。免疫组织化学染色分析HIF-1α,CA-IX,GLUT-1和VEGF的表达。 54例中,HIF-1α阳性28例,CA-IX 35例,GLUT-1 40例,VEGF 23例。结果表明,HIF-1α的表达与肿瘤的分期和组织学相关,CA-IX的表达与肿瘤的分期,肿瘤的大小,淋巴结转移和淋巴血管的空间大小有关,GLUT-1的表达与肿瘤的分期和淋巴血管的空间大小相关。和VEGF表达与微血管密度有关。多元回归分析表明,CA-IX表达和淋巴管空间受累是与淋巴结转移相关的独立变量。 CA-IX或VEGF表达阳性的患者的无进展生存期短于CA-IX或VEGF表达阴性的患者的无进展生存期。对于CA-IX表达阳性的患者,根治性子宫切除术后接受放射治疗或化学放射治疗的患者的无进展生存期也较短。这些发现表明,CA-IX表达是局部晚期宫颈癌患者淋巴结转移和疾病复发的可能危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号